Evaluating the distinct pleiotropic effects of omega-3 fatty acids on type 2 diabetes mellitus: a mendelian randomization study
Authors:
Open Access
- 7 June 2023
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 21 (1) , 1-11
Abstract
Background: Observational studies and conventional Mendelian randomization (MR) studies showed inconclusive evidence to support the association between omega-3 fatty acids and type 2 diabetes. We aim to evaluate the causal effect of omega-3 fatty acids on type 2 diabetes mellitus (T2DM), and the distinct intermediate phenotypes linking the two. Methods: Two-sample MR was performed using genetic instruments derived from a recent genome-wide association study (GWAS) of omega-3 fatty acids (N = 114,999) from UK Biobank and outcome data obtained from a large-scale T2DM GWAS (62,892 cases and 596,424 controls) in European ancestry. MR-Clust was applied to determine clustered genetic instruments of omega-3 fatty acids that influences T2DM. Two-step MR analysis was used to identify potential intermediate phenotypes (e.g. glycemic traits) that linking omega-3 fatty acids with T2DM. Results: Univariate MR showed heterogenous effect of omega-3 fatty acids on T2DM. At least two pleiotropic effects between omega-3 fatty acids and T2DM were identified using MR-Clust. For cluster 1 with seven instruments, increasing omega-3 fatty acids reduced T2DM risk (OR: 0.52, 95%CI 0.45–0.59), and decreased HOMA-IR (β = − 0.13, SE = 0.05, P = 0.02). On the contrary, MR analysis using 10 instruments in cluster 2 showed that increasing omega-3 fatty acids increased T2DM risk (OR:1.10; 95%CI 1.06–1.15), and decreased HOMA-B (β = − 0.04, SE = 0.01, P = 4.52 × 10–5). Two-step MR indicated that increasing omega-3 fatty acid levels decreased T2DM risk via decreasing HOMA-IR in cluster 1, while increased T2DM risk via decreasing HOMA-B in cluster 2. Conclusions: This study provides evidence to support two distinct pleiotropic effects of omega-3 fatty acids on T2DM risk influenced by different gene clusters, which could be partially explained by distinct effects of omega-3 fatty acids on insulin resistance and beta cell dysfunction. The pleiotropic feature of omega-3 fatty acids variants and its complex relationships with T2DM need to be carefully considered in future genetic and clinical studies.Keywords
Funding Information
- National Natural Science Foundation of China (81970691, 82170819)
- Shanghai Outstanding Academic Leaders Plan (20XD1422800)
- Shanghai Medical and Health development foundation (DMRFP_I_01)
- Clinical Research Plan of SHDC (SHDC2020CR3064B)
- Science and Technology Committee of Shanghai (20Y11905100, 19411964200)
- Heart and Stroke Foundation of British Columbia and Yukon (SBF006\1117)
- UK Medical Research Council Skills Development Fellowship (MR/P014054/1)
This publication has 49 references indexed in Scilit:
- Delta-5 and Delta-6 Desaturases: Crucial Enzymes in Polyunsaturated Fatty Acid-Related Pathways with Pleiotropic Influences in Health and Disease2014
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- The Role of Diet in Prevention and Management of Type 2 Diabetes: Implications for Public HealthCritical Reviews in Food Science and Nutrition, 2012
- Lipid-Induced Mitochondrial Stress and Insulin Action in MuscleCell Metabolism, 2012
- Fish Consumption, Dietary Long-Chain n-3 Fatty Acids, and Risk of Type 2 DiabetesDiabetes Care, 2012
- Omega-3 Fatty Acids and Cardiovascular DiseaseJACC, 2011
- Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetesThe American Journal of Clinical Nutrition, 2011
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing EffectsCell, 2010
- Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitusThe American Journal of Clinical Nutrition, 2009
- Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes MellitusMayo Clinic Proceedings, 2003